All questions
Indication: Opdivo (nivolumab) in metastatic non-small cell lung cancer
5 questions · 5 sources
Indication questions that apply to every indication of Opdivo are on Opdivo (nivolumab), all indications: Indication.
Indication
What is Opdivo approved for in metastatic non-small cell lung cancer?
What is Opdivo Qvantig approved for in metastatic NSCLC?
Applies to Metastatic NSCLC in adults with progression on or after platinum-based chemotherapy: OPDIVO QVANTIG monotherapy
Can Opdivo Qvantig be given with Yervoy for lung cancer?
Applies to Metastatic NSCLC in adults with progression on or after platinum-based chemotherapy: OPDIVO QVANTIG monotherapy
Testing
Does Opdivo plus Yervoy require PD-L1 testing in metastatic NSCLC?
Applies to First-line metastatic NSCLC in adults whose tumors express PD-L1 (≥1%), with no EGFR or ALK genomic tumor aberrations: OPDIVO with YERVOY (Checkmate 227)
Note: The quoted PD-L1 selection statement applies to first-line Opdivo with Yervoy.
Eligibility
Can Opdivo be used for lung cancer with EGFR or ALK mutations?